Hawktail

Terrain BioSciences is in the field of RNA-based therapeutics and vaccine development. Leveraging advanced AI and proprietary manufacturing platforms, Terrain BioSciences addresses the challenges of designing, selecting, manufacturing, and delivering optimal RNA sequences. Terrain BioSciences collaborates with over a dozen biotech firms to enhance the expression, durability, and manufacturability of RNA sequences, significantly accelerating their path to clinical application. With a focus on personalized cancer vaccines and other RNA-based modalities, Terrain BioSciences is at the forefront of the next generation of programmable medicines.

ExpressionEdits is a biotechnology company focused on enhancing the redesign of synthetic DNA instructions to improve protein expression. Utilizing an AI-driven approach, the company aims to transform the standards of protein production, which is crucial for advancements in healthcare and biotechnology. ExpressionEdits operates a research platform specifically designed to enhance transgene expression in mammalian systems, thereby increasing recombinant protein yields and improving the quality and efficacy of DNA medicines. The team comprises scientists and engineers who are committed to developing innovative technologies that align with biological processes found in nature, ultimately supporting researchers in their efforts to understand genetic inheritance of transgenes.

Cache is a biotechnology company focused on developing a groundbreaking wet operating system designed for the storage, access, and computation of biomolecules at scale. By ensuring the integrity and fidelity of nucleic acids from various sources, Cache enables researchers and partners to accelerate molecular pathology research and gain insights into life sciences. This innovative approach facilitates the analysis of biomolecules, thereby unlocking new precision medicine applications and enhancing the capacity for understanding biological data. Ultimately, Cache aims to make both digital and biological data universally accessible and sustainable, eliminating the need for data deletion or disposal.

OverT Bio is a biotechnology company focused on developing cell therapies for cancer treatment. The company specializes in identifying and creating novel genetic modifications that empower immune cells to navigate and overcome the obstacles posed by tumors. Through its innovative approach, OverT Bio aims to enhance the effectiveness and durability of immunotherapies, contributing to advancements in cancer identification and treatment within the healthcare sector.

A market leader​ ​in providing network and security solutions to enterprises.

Zafrens is a drug discovery company founded in 2021 and headquartered in San Diego, California. It focuses on developing life sciences products that facilitate the detailed characterization of diverse cell populations. The company's innovative platform provides a resolution approach to studying interactions between cells and drugs, as well as between different cell types, by directly mapping the molecular states of individual cells. Zafrens leverages large volumes of curated experimental data to train artificial intelligence models for drug discovery, enhancing its capabilities in T cell immunotherapies and ribonucleic acid regulation. By integrating insights from biology, chemistry, and engineering, Zafrens aims to advance the medical industry with its proprietary data and experimental techniques.

Bring all of your company data together and use it with the best AI tools.

Reask is a technology-focused company specializing in natural hazard modeling, particularly for weather-related catastrophes. It offers real-time and post-event analysis, along with long-term predictive solutions powered by artificial intelligence. Reask's core services include global risk mapping and probabilistic trend forecasting to help businesses assess and manage their catastrophe risk exposure effectively.

Standard Fleet is a developer of software tailored for electric fleet businesses, focusing on enhancing operational efficiency in sectors such as delivery, rental, car sharing, leasing, and taxi services. The company creates custom online and mobile tools that help clients track vehicle charging, manage trip expenses, and generate detailed activity and mileage reports. Additionally, the software provides alerts for battery health, tire maintenance, and wear reduction, allowing users to optimize the performance and profitability of their electric vehicle fleets. Founded by a former CEO of a transportation startup acquired by Apple, Standard Fleet is supported by a team of experienced professionals from leading technology companies, including Apple and Tesla, who aim to make a significant impact in the electric vehicle industry.

Gridware is focused on enhancing and safeguarding the electrical grid, a critical infrastructure that, when compromised, can lead to severe consequences such as wildfires, property damage, and loss of life. The company has developed an advanced monitoring system that employs high-precision sensor arrays, including microphones and other sensing technologies, to continuously analyze the electrical and mechanical behavior of grid assets. This system incorporates an artificial intelligence processing unit that detects anomalies in the environment around power poles, enabling utilities to proactively address potential faults. By facilitating timely repairs and rapid responses to climatic anomalies, Gridware's technology improves safety, reliability, and reduces outage durations for utility companies. Headquartered in the Bay Area of Northern California, Gridware is privately held and supported by notable climate-tech and Silicon Valley investors, positioning itself to meet the growing demand for power while contributing to the future resilience of the electrical grid.

Range Biotechnologies is a developer of translational proteomics technology aimed at advancing human health. The company focuses on creating innovative tools that enable personalized health by allowing for the precise measurement of multiple proteins across numerous samples simultaneously. This capability provides healthcare professionals with critical insights into the fundamental mechanisms of diseases and their evolution over time, facilitating a deeper understanding of health conditions and informing more effective treatment strategies.

Modulo Bio simulates the neuroimmune system to find medication candidates that target microglia cells. The organization's proprietary neuroimmune platform combines the most recent developments in stem cell biology and neuroscience with software, automation, and artificial intelligence to create novel treatments.

DREM is an operator of an energy-saving platform focused on simplifying the deployment of heat pumps for residential properties. The company facilitates a seamless buying process by connecting homeowners with qualified local installers, streamlining lead generation and hardware procurement. Through direct marketplace integrations with manufacturers, DREM enhances the renovation experience for homeowners, making it easier to undertake projects such as heating system upgrades, roof replacements, and painting. By centralizing these services, DREM aims to improve energy efficiency and simplify the overall renovation process for its clients.

BurnBot is a provider of innovative fuel treatment services aimed at preventing destructive wildfires. The company specializes in systematic wildfire mitigation and vegetation management by utilizing advanced forestry and fire technology. BurnBot offers solutions that include safe smoke containment and a modular system for controlled burns, which can be strategically deployed near homes and valuable assets. By employing high-temperature ignition methods, BurnBot helps create effective firebreaks and defensible spaces, thereby protecting communities, infrastructure, and natural resources from the threat of wildfires.

Eigen Therapeutics is a biotechnology company dedicated to advancing cancer treatment through the development of innovative therapies. It specializes in "priming" therapies that enhance the effectiveness of targeted treatments by addressing cancer heterogeneity, which makes cancer cells more susceptible to therapeutic interventions while simultaneously protecting healthy cells. Eigen is creating a high-throughput discovery platform that integrates proprietary machine learning algorithms to identify novel drug classes and therapeutic approaches capable of altering a cell’s state to increase vulnerability to treatments. This platform combines biology and engineering, utilizing in-house developed robotic systems, laboratory operations software, and machine learning analysis pipelines. The company's mission focuses on improving patient outcomes by providing novel combination therapeutics that enhance efficacy and reduce toxicity in cancer care, ultimately aiming to meet significant medical needs in oncology.

Rezo Therapeutics is a biotechnology company that focuses on pioneering the integrated mapping of disease networks to develop precision therapeutics. Utilizing its proprietary Sequence to Systems to Drugs (SSD) platform, Rezo combines proteomics, genetics, structural biology, chemistry, and bioinformatics to create comprehensive maps of molecular disease networks. This innovative approach enables oncologists and researchers to identify novel targets and therapies with greater clarity and precision than traditional drug discovery methods. Initially concentrating on oncology, Rezo Therapeutics plans to expand its therapeutic focus through collaborations and partnerships, aiming to address a wide range of diseases.

Kaleidoscope is a collaborative, cloud-based research platform for organizing and tracking scientific activities.

Seabound is a developer of innovative carbon capture systems aimed at reducing CO2 emissions from cargo ships. The company's technology integrates seamlessly with existing vessels, equipping them with an onboard device that captures emissions from exhaust and converts carbon dioxide into a solid form. This solidified carbon can be stored for future utilization or sequestration, significantly mitigating greenhouse gas emissions and pollution associated with maritime transport. Additionally, Seabound's carbon capture method enables the processing of carbon dioxide on land, producing limestone that can be sold directly or transformed into calcium oxide for secondary recycling. Through its advancements, Seabound contributes to the sustainability of shipping operations and supports efforts to combat climate change.

Adaptyv Bio is a biotechnology company focused on developing a protein engineering platform that leverages cell-free synthetic biology and high-throughput nanofluidics. The company's innovative technology aims to identify new antibodies for the treatment of various diseases by bridging the gap between computational predictions and experimental validation. Through its advanced methodologies, Adaptyv Bio seeks to enhance the efficacy of therapeutic interventions, ultimately improving patient outcomes.

Reask is a technology-focused company specializing in natural hazard modeling, particularly for weather-related catastrophes. It offers real-time and post-event analysis, along with long-term predictive solutions powered by artificial intelligence. Reask's core services include global risk mapping and probabilistic trend forecasting to help businesses assess and manage their catastrophe risk exposure effectively.